---
title: "Applications: Viral hepatitis"
description: Develop best-in-class therapeutics for hepatitis viruses using the PXB-mouse® and PXB-cells®
---

[![PhoenixBio logo](https://www.phoenixbio.com/hubfs/Blend01/Logos/PhoenixBio_logo.svg) ](https://www.phoenixbio.com?hsLang=en)

- [ Products ](https://www.phoenixbio.com/products?hsLang=en)
  
    - [PXB-mouse®](https://www.phoenixbio.com/products/pxb-mouse?hsLang=en)
    - [PXB-cells®](https://www.phoenixbio.com/products/pxb-cells?hsLang=en)
- [ Applications ](https://www.phoenixbio.com/applications?hsLang=en)
  
    - [Gene-based Therapeutics](https://www.phoenixbio.com/applications/gene-based-therapeutics?hsLang=en)
    - [MASH/MAFLD](https://www.phoenixbio.com/applications/humanized-liver-mash-mafld-model?hsLang=en)
    - [Viral Hepatitis](https://www.phoenixbio.com/applications/viral-hepatitis)
    - [DMPK/Toxicity](https://www.phoenixbio.com/applications/dmpk-toxicity?hsLang=en)
    - [Custom Transplantations](https://www.phoenixbio.com/applications/custom-transplantations?hsLang=en)
- Resources
  
    - [Resources Hub](https://www.phoenixbio.com/resources-hub?hsLang=en)
    - [Blog, News, Events](https://www.phoenixbio.com/news?hsLang=en)
- About us
  
    - [About PhoenixBio](https://www.phoenixbio.com/about-us?hsLang=en)
    - [Company Profile](https://www.phoenixbio.com/about-us/company-profile?hsLang=en)
    - [Bioethics](https://www.phoenixbio.com/bioethics?hsLang=en)
    - [Partners and Affiliates](https://www.phoenixbio.com/about-us/partners-and-affiliates?hsLang=en)
- [ Japanese ](https://phoenixbio.co.jp)
- [ Contact us ](https://www.phoenixbio.com/contact?hsLang=en)

[![PhoenixBio logo](https://www.phoenixbio.com/hubfs/Blend01/Logos/PhoenixBio_logo.svg) ](https://www.phoenixbio.com?hsLang=en)

- [ Products ](https://www.phoenixbio.com/products?hsLang=en)
  
  
  
    - [PXB-mouse®](https://www.phoenixbio.com/products/pxb-mouse?hsLang=en)
    - [PXB-cells®](https://www.phoenixbio.com/products/pxb-cells?hsLang=en)
- [ Applications ](https://www.phoenixbio.com/applications?hsLang=en)
  
  
  
    - [Gene-based Therapeutics](https://www.phoenixbio.com/applications/gene-based-therapeutics?hsLang=en)
    - [MASH/MAFLD](https://www.phoenixbio.com/applications/humanized-liver-mash-mafld-model?hsLang=en)
    - [Viral Hepatitis](https://www.phoenixbio.com/applications/viral-hepatitis)
    - [DMPK/Toxicity](https://www.phoenixbio.com/applications/dmpk-toxicity?hsLang=en)
    - [Custom Transplantations](https://www.phoenixbio.com/applications/custom-transplantations?hsLang=en)
- Resources
  
  
  
    - [Resources Hub](https://www.phoenixbio.com/resources-hub?hsLang=en)
    - [Blog, News, Events](https://www.phoenixbio.com/news?hsLang=en)
- About us
  
  
  
    - [About PhoenixBio](https://www.phoenixbio.com/about-us?hsLang=en)
    - [Company Profile](https://www.phoenixbio.com/about-us/company-profile?hsLang=en)
    - [Bioethics](https://www.phoenixbio.com/bioethics?hsLang=en)
    - [Partners and Affiliates](https://www.phoenixbio.com/about-us/partners-and-affiliates?hsLang=en)
- [ Japanese ](https://phoenixbio.co.jp)
- [ Contact us ](https://www.phoenixbio.com/contact?hsLang=en)

# Viral Hepatitis (HCV, HBV, HDV/HBV)

Test anti-viral therapeutics with immediate relevance for human physiology in the PXB-mouse® and PXB-cells® models.

![virus](https://www.phoenixbio.com/hubfs/virus.svg)

<https://www.phoenixbio.com/applications/viral-hepatitis#TheChallenge>

[

#### Discover more about how PXB-mice and PXB-cells® are boosting the successes of ongoing viral hepatitis research

Resources Hub

](https://www.phoenixbio.com/resources-hub?applications=Viral+Hepatitis+%28HBV%29%2CViral+Hepatitis+%28HCV%29&types=Publications&hsLang=en)

## The challenge

Due to the high species-specificity of hepatitis viruses, the success of your anti-viral therapeutics during clinical trials is highly influenced by the translational potential of the animal model used during preclinical research.

Gather highly translational insights into human outcomes during the preclinical testing of anti-viral therapeutics with our PXB-mouse® and PXB-cells® with human liver environments.

Our commercial scale production ensures that high quality PXB-mice are always available for your studies. A dedicated project management team will work with you on study design, feasibility, and execution — providing real-time solutions and regular reporting to ensure momentum is maintained throughout the study timeframe.

## Viral hepatitis infection *in vivo* and *in vitro* with PXB-mice and PXB-cells®

Demonstrate antiviral efficacy in the development of your best-in-class therapeutics for viral hepatitis viruses, including hepatitis B, C and D virus, with unrivalled translational potential using PXB-mice and PXB-cells®.

We provide a full translational platform for viral hepatitis from *in vitro*, with our PXB-cells®, to *in vivo*, using PXB-mice. These products are ideal for viral hepatitis drug development as they support a viral infection comparable to humans and a human hepatocyte metabolism of compounds to increase confidence in your compound’s efficacy, tolerability, and safety.

![mouse_icon](https://www.phoenixbio.com/hubfs/Website/Pages/Applications/mouse_icon.svg)

### *In vivo*: PXB-mice

Chimeric mice with a humanized liver

[Find out more](https://www.phoenixbio.com/products/pxb-mouse?hsLang=en)

![in_vitro_cells_icon](https://www.phoenixbio.com/hubfs/Website/Pages/Applications/in_vitro_cells_icon.svg)

### *In vitro*: PXB-cells®

Primary human hepatocytes freshly isolated from PXB-mice

[Find out more](https://www.phoenixbio.com/products/pxb-cells?hsLang=en)

#### HBV inocula available and measurement parameters included in PhoenixBio study services

Inoculum genotypes available for HBV infection

| **Genotype** | **Subtype (Serotype)** |
| --- | --- |
| Ae | adw |
| Bj | adw |
| C | adr |
| D | ayw |

Genotypes Ae, Bj, C and D are available as HBV inocula for the in vivo HBV studies.

Serum assays specific for HBV

| **Parameter** |
| --- |
| HBV DNA |
| HBsAg |
| HBeAg |
| HBcrAg (HB core-related Ag) |

Analysis of blood biochemistry such as h-ALT1, ALT, AST, and others can be provided as well.

Liver assays specific to HBV

| **Parameter** |
| --- |
| HBV DNA |
| cccDNA |
| HBsAg (via immunostaining) |
| HBcAg (via immunostaining) |
| DNA Polymerase Activity |

## Support all stages of hepatitis viral life cycles in PXB-mice and PXB-cells®

The viral-hepatitis infected PXB-mouse® is a powerful tool for evaluating the efficacy of anti-viral agents in a therapeutic or prophylactic approach. Model all stages of the Hepatitis B virus life cycle, including the formation of cccDNA, with the use of our chimeric mouse model with a highly humanized liver.

Our HBV-infected PXB-mouse® study services include the following in our Biosafety Level 2 (BSL2) facility:

- Anti-viral efficacy (therapeutic or prophylactic)
- Infectivity research

[ Contact us to learn more ](https://www.phoenixbio.com/contact?hsLang=en)

## Evaluate Therapeutic Efficacy in an Extensively Validated Model

The PXB-mouse has been well characterized using approved therapeutics that target viral hepatitis. It is ideal for testing a wide variety of therapeutic modalities including small molecules and gene therapies. 

Coupled with our extensive expertise in analyzing the markers of HBV infection, the PXB-mouse provides an ideal platform to understand the antiviral efficacy of your novel therapeutic.

 

[ Discover our latest HBV Promotions ](https://www.phoenixbio.com/news/hbv-in-humanized-liver-mouse?hsLang=en)

[

#### Learn how the PXB-mouse enables evaluation of novel anti-HBV therapeutics

Blog Post

](https://www.phoenixbio.com/news/hbv-in-humanized-liver-mouse?hsLang=en)

## Predict the human-specific toxicity and pharmacokinetics of your therapeutic agents

Get the most value out of your HBV research experiments with pharmacokinetic and toxicity assessment using our PXB-mouse® model and its humanized liver.

Confidently move forward to your viral hepatitis efficacy studies upon evaluation of your compound’s predicted human pharmacokinetics and human-specific toxicity. We offer study design strategies beginning with preliminary tolerability, pharmacokinetic, or toxicity studies prior to viral-hepatitis efficacy studies. Throughout viral-hepatitis efficacy studies, continue to monitor the pharmacokinetics and human-specific toxicity of your therapeutic agents to boost data collection and to realize the true potential of the PXB-mouse model.

[ Explore DMPK/Toxicity ](https://www.phoenixbio.com/applications/dmpk-toxicity?hsLang=en)

**Our clients typically add-on pharmacokinetic and toxicity assessments:**

- Before major HBV studies to confirm and predict tolerability, PK, or toxicity in a humanized liver environment.
- In an HBV efficacy study to maximise their findings by adding PK or toxicity assessment to result in more comprehensive data.

[ Contact us ](https://www.phoenixbio.com/contact?hsLang=en)

## Find out how we help your viral hepatitis drug development projects

[ Contact us ](https://www.phoenixbio.com/contact?hsLang=en)

### [Products](https://www.phoenixbio.com/products?hsLang=en)

[PXB-mouse®](https://www.phoenixbio.com/products/pxb-mouse?hsLang=en)

[PXB-cells®](https://www.phoenixbio.com/products/pxb-cells?hsLang=en)

### [Applications](https://www.phoenixbio.com/applications?hsLang=en)

[MASH/MAFLD](https://www.phoenixbio.com/applications/humanized-liver-mash-mafld-model?hsLang=en)

[Viral Hepatitis](https://www.phoenixbio.com/applications/viral-hepatitis?hsLang=en)

[Gene-Based Therapeutics](https://www.phoenixbio.com/applications/gene-based-therapeutics?hsLang=en)

[DMPK/Toxicity](https://www.phoenixbio.com/applications/dmpk-toxicity?hsLang=en)

[Custom Transplantations](https://www.phoenixbio.com/applications/custom-transplantations?hsLang=en)

### Resources

[Resources Hub](https://www.phoenixbio.com/resources-hub?hsLang=en)

[Blog, News & Events](https://www.phoenixbio.com/news?hsLang=en)

### About us

[About PhoenixBio](https://www.phoenixbio.com/about-us?hsLang=en)

[Company Profile](https://www.phoenixbio.com/about-us/company-profile?hsLang=en)

[Bioethics](https://www.phoenixbio.com/bioethics?hsLang=en)

[Partners & Affiliates](https://www.phoenixbio.com/about-us/partners-and-affiliates?hsLang=en)

### Contact us

**USA Office**  
Tel. [+1-212-379-6411](tel:+1-212-379-6411)  
Fax +1-212-379-6422  
[1120 6th Ave, Suite 1513, New York, NY, 10036 USA](https://www.google.com/maps/place/1120+6th+Ave+%231513,+New+York,+NY+10036/@40.755606,-73.9854239,17z/data=!4m6!3m5!1s0x89c258fff8490a41:0xd08c7c44e07f7d41!8m2!3d40.755606!4d-73.982849!16s%2Fg%2F11n09bvj66)

**Japan Office**  
[3-4-1, Kagamiyama,  
Higashi-Hiroshima City,  
739-0046, Japan](https://goo.gl/maps/9pke8DGcK6NgYu9B8)

[Contact us](https://www.phoenixbio.com/contact?hsLang=en)

![PhoenixBio logo](https://www.phoenixbio.com/hubfs/Blend01/Logos/PhoenixBio_logo.svg)

<https://www.linkedin.com/company/phoenixbio/>

© 2026 PhoenixBio Co., Ltd. All Rights Reserved.  
PhoenixBio, PXB-mouse®, PXB-cells® and Corporate Mark are registered trademarks of PhoenixBio.

[Terms & conditions](https://www.phoenixbio.com/terms?hsLang=en)[Privacy Policy](https://www.phoenixbio.com/privacy-policy?hsLang=en)